Susquehanna Fundamental Investments’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-54,179
Closed -$805K 1045
2022
Q4
$805K Buy
54,179
+41,779
+337% +$682K 0.01% 722
2022
Q3
$205K Buy
+12,400
New +$250K ﹤0.01% 1254
2022
Q1
$1.54M Buy
65,704
+57,833
+735% +$1.42M 0.03% 681
2021
Q4
$214K Sell
7,871
-70,519
-90% -$1.89M 0.01% 1221
2021
Q3
$2.23M Buy
78,390
+5,806
+8% +$177K 0.04% 558
2021
Q2
$2.19M Buy
72,584
+900
+1% +$26.6K 0.04% 574
2021
Q1
$1.83M Buy
71,684
+5,560
+8% +$142K 0.03% 677
2020
Q4
$1.62M Buy
66,124
+38,644
+141% +$726K 0.03% 692
2020
Q3
$447K Buy
+27,480
New +$511K 0.01% 919

Other funds holding MD

Susquehanna Fundamental Investments's MD Position: Q1 2023 in Review

Susquehanna Fundamental Investments sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 54,179 shares — an estimated $805K sold.

Susquehanna Fundamental Investments first reported a position in MD in Q3 2020 and held it in 9 quarters. The position peaked at $2.23M in Q3 2021. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

  • Susquehanna Fundamental Investments reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 54,179 Pediatrix Medical shares in Q1 2023, an estimated $805K.
  • Susquehanna Fundamental Investments first reported a position in Pediatrix Medical in Q3 2020 and held it in 9 quarters.
  • Susquehanna Fundamental Investments's Pediatrix Medical position peaked at $2.23M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2023, filed 16 May 2023.